Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TACO1 regulates mitochondrial adaptation in hypertension-induced cardiac remodeling and heart failure.

Research square·2026
Same author

The MICOS Complex Regulates Mitochondrial Structure and Oxidative Stress During Age-Dependent Structural Deficits in the Kidney.

Aging cell·2026
Same author

A sodium-HIF1α axis coordinates immune metabolic reprogramming and mitochondrial remodeling in salt-sensitive hypertension.

Research square·2026
Same author

ATF4 Coordinates Transcriptomic and Structural Adaptations in Aging Muscle.

bioRxiv : the preprint server for biology·2026
Same author

Stress-Encoded Mitochondrial Plasticity: ATF4 Control of Mega-Mitochondria and Nanotunnel Communication.

bioRxiv : the preprint server for biology·2026
Same author

Point-of-Care Urine Tenofovir Drug-Level Feedback Counseling Improves Long-Term Pre-exposure Prophylaxis Adherence for US Men Who Have Sex With Men in Pilot RCT.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Related Experiment Video

Updated: May 22, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

A flow cytometry-based dopamine transporter binding assay using antagonist-conjugated quantum dots.

Oleg Kovtun1, Emily J Ross, Ian D Tomlinson

  • 1Department of Chemistry, Vanderbilt University, 7300 Stevenson Ctr Ln, Nashville, TN 37235, USA.

Chemical Communications (Cambridge, England)
|May 1, 2012
PubMed
Summary

We developed a new assay using quantum dots (QDs) to measure dopamine transporter (DAT) binding. This method is valuable for efficiently screening new DAT modulators.

More Related Videos

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads
07:13

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads

Published on: June 28, 2024

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

Related Experiment Videos

Last Updated: May 22, 2026

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum
10:19

High-throughput Flow Cytometry Cell-based Assay to Detect Antibodies to N-Methyl-D-aspartate Receptor or Dopamine-2 Receptor in Human Serum

Published on: November 23, 2013

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads
07:13

Fluorescent Lateral Flow Immunoassay Based on Quantum Dots Nanobeads

Published on: June 28, 2024

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

Area of Science:

  • Neuroscience
  • Biochemistry
  • Analytical Chemistry

Background:

  • The dopamine transporter (DAT) is a key regulator of dopaminergic neurotransmission.
  • Developing efficient methods for screening DAT modulators is crucial for understanding and treating neurological disorders.

Purpose of the Study:

  • To develop and validate a novel flow cytometry-based assay for measuring dopamine transporter (DAT) binding.
  • To utilize antagonist-conjugated quantum dots (QDs) for DAT binding detection.

Main Methods:

  • Development of a flow cytometry assay utilizing quantum dots (QDs) conjugated with DAT antagonists.
  • Validation of the QD-based assay for DAT binding measurements.

Main Results:

  • Successful development and validation of a flow cytometry-based DAT binding assay.
  • Demonstration of the assay's utility with antagonist-conjugated QDs.

Conclusions:

  • The developed QD-based assay provides a robust method for DAT binding assessment.
  • This assay is highly valuable for high-throughput screening of novel dopamine transporter (DAT) modulators.